33,047
Views
44
CrossRef citations to date
0
Altmetric
Women's Health

Use of dienogest in endometriosis: a narrative literature review and expert commentary

, , , , , & show all
Pages 895-907 | Received 13 Nov 2019, Accepted 11 Mar 2020, Published online: 31 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Francesco La Torre, Silvia Vannuccini, Federico Toscano, Ernesto Gallucci, Gretha Orlandi, Virginia Manzi & Felice Petraglia. (2024) Long-term treatment for endometriosis with dienogest: efficacy, side effects and tolerability. Gynecological Endocrinology 40:1.
Read now
Umberto Perrone, Giulio Evangelisti, Antonio Simone Laganà, Stefano Bogliolo, Marcello Ceccaroni, Alberto Izzotti, Claudio Gustavino, Simone Ferrero & Fabio Barra. (2023) A review of phase II and III drugs for the treatment and management of endometriosis. Expert Opinion on Emerging Drugs 28:4, pages 333-351.
Read now
Ilaria Piacenti, Maria Federica Viscardi, Luisa Masciullo, Chiara Sangiuliano, Sara Scaramuzzino, Maria Grazia Piccioni, Ludovico Muzii, Pierluigi Benedetti Panici & Maria Grazia Porpora. (2021) Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what’s the best choice?. Gynecological Endocrinology 37:5, pages 471-475.
Read now

Articles from other publishers (41)

Han Wu, Jun-Jiang Liu, Sheng-Tou Ye, Jun Liu & Na Li. (2024) Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 297, pages 40-49.
Crossref
Peter S. Thiel, Francesca Donders, Anna Kobylianskii, Sarah Maheux-Lacroix, John Matelski, Chris Walsh & Ally Murji. (2024) The Effect of Hormonal Treatment on Ovarian Endometriomas: A Systematic Review and Meta-Analysis. Journal of Minimally Invasive Gynecology 31:4, pages 273-279.
Crossref
Meiling Wu, Qingfei Zhang, Luoran Shang & Ping Duan. (2024) Microfluidics-derived hierarchical microparticles for the delivery of dienogest for localized endometriosis therapy. Acta Biomaterialia 178, pages 257-264.
Crossref
Melinda-Ildiko Mitranovici, Diana Maria Chiorean, Liviu Moraru, Raluca Moraru, Laura Caravia, Andreea Taisia Tiron, Titiana Cornelia Cotoi, Havva Serap Toru & Ovidiu Simion Cotoi. (2024) Shared Pathogenic and Therapeutic Characteristics of Endometriosis, Adenomyosis, and Endometrial Cancer: A Comprehensive Literature Review. Pharmaceuticals 17:3, pages 311.
Crossref
Takae Hirono, Ye Feng, Wenhui Wang & Huan Yu. (2024) Spontaneous recurrent menstrual pneumothorax: a case report. Annals of Medicine & Surgery 86:2, pages 1096-1100.
Crossref
Paolo Vercellini, Veronica Bandini, Paola Viganò, Deborah Ambruoso, Giulia Emily Cetera & Edgardo Somigliana. (2024) Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions. Human Reproduction 39:1, pages 18-34.
Crossref
Alexa Eberle, Dong Bach Nguyen, Jessica Papillon Smith, Fady W. Mansour, Srinivasan Krishnamurthy & Andrew Zakhari. (2024) Medical Management of Ovarian Endometriomas. Obstetrics & Gynecology 143:1, pages 53-66.
Crossref
Anna Egorova, Marianna Maretina, Iuliia Krylova & Anton Kiselev. (2023) Polycondensed Peptide-Based Polymers for Targeted Delivery of Anti-Angiogenic siRNA to Treat Endometriosis. International Journal of Molecular Sciences 25:1, pages 13.
Crossref
Joowon Lee, Hyeon Ji Park & Kyong Wook Yi. (2023) Dienogest in endometriosis treatment: A narrative literature review. Clinical and Experimental Reproductive Medicine 50:4, pages 223-229.
Crossref
Hervé Fernandez, Aubert Agostini, Hortense Baffet, Nathalie Chabbert-Buffet, Philippe Descamps, Jean-Philippe Estrade, Géraldine Giraudet, Claude Hocke, Bruno Salle, Florence Tremollieres & Charles Chapron. (2023) Update on the management of endometriosis-associated pain in France. Journal of Gynecology Obstetrics and Human Reproduction 52:9, pages 102664.
Crossref
Anuja Pant, Kareena Moar, Taruna K. Arora & Pawan Kumar Maurya. (2023) Biomarkers of endometriosis. Clinica Chimica Acta 549, pages 117563.
Crossref
Anna Egorova, Mariya Petrosyan, Marianna Maretina, Elena Bazian, Iuliia Krylova, Vladislav Baranov & Anton Kiselev. (2023) iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis. Pharmaceutics 15:8, pages 2108.
Crossref
Michel Canis & Sun-Wei Guo. (2023) In the thicket of fears, doubts, and murky facts: some reflections on treatment modalities for endometriosis-associated pain. Human Reproduction 38:7, pages 1245-1252.
Crossref
Han Kyul Kim, Eun-San Kim, Kyoung Sun Park, Yoon Jae Lee & In-Hyuk Ha. (2023) Current treatments for endometriosis in South Korea: an analysis of nationwide data from 2010 to 2019. Scientific Reports 13:1.
Crossref
Thomas Römer. (2023) Medikamentöse Therapie der Endometriose – ein UpdateTraitement médicamenteux de l’endométriose – une mise à jour. Wiener klinisches Magazin 26:3, pages 134-140.
Crossref
I. V. Kuznetsova. (2023) The use of combined oral contraceptives in patients with endometriosis. Medical alphabet:3, pages 14-20.
Crossref
Lei Han, Yanni Liu, Kaixue Lao, Jianxi Jiang, Caiying Zhang & Yanlin Wang. (2023) Individualized conservative therapeutic strategies for adenomyosis with the aim of preserving fertility. Frontiers in Medicine 10.
Crossref
Marzieh Vahid-Dastjerdi, Reihaneh Hosseini, Hanieh Rodi, Hadith Rastad & Ladan Hosseini. (2023) Comparison of the effectiveness of Dienogest with medroxyprogesterone acetate in the treatment of pelvic pain and recurrence of endometriosis after laparoscopic surgery. Archives of Gynecology and Obstetrics 308:1, pages 149-155.
Crossref
Surekha Tayade, Sangeeta Rai, Hrishikesh Pai, Madhuri Patel & Nidhi Makhija. (2023) Efficacy of Dienogest in Adolescent Endometriosis: A Narrative Review. Cureus.
Crossref
Antonio Maiorana, Pietro Alfano, Antonella Mercurio, Salvatore Marcantonio, Gabriella Minneci, Domenico Incandela & Palma Audino. (2023) Quality of life and clinical factors in women with endometriosis, the role of dienogest vs EE/dienogest over time: a single-center study. Archives of Gynecology and Obstetrics 307:5, pages 1503-1512.
Crossref
Abdulelah lAdimi, Nabil AlOdaini & Atef M. M. Darwish. (2022) Sequential treatment with transurethral resection and hormonal therapy for bladder endometriosis of vesicoureteric junction. Journal of Medicine and Life Science 19:3, pages 116-120.
Crossref
I. A. Ivanov. (2022) The issues of endometriosis hormonal treatment in reproductive age women. Meditsinskiy sovet = Medical Council:6, pages 157-163.
Crossref
Thomas Römer. (2022) Medikamentöse Therapie der Endometriose – ein UpdateTraitement médicamenteux de l’endométriose – une mise à jour. Journal für Gynäkologische Endokrinologie/Schweiz 25:4, pages 168-175.
Crossref
Vishal Bahall, Lance De Barry & Keevan Singh. (2022) Thoracic endometriosis masquerading as Meigs' syndrome in a young woman: A case report and literature review. Case Reports in Women's Health 36, pages e00452.
Crossref
Luiz R. GUIMARÃES FERREIRA, Teresa CAVALCANTI, Monica ZOMER, William KONDO, Edward ARAUJO JÚNIOR & Jaime KULAK JUNIOR. (2022) Estrogen and progesterone receptors in endometriosis. Minerva Obstetrics and Gynecology 74:4.
Crossref
Natalia M. Podzolkova, Igor E. Fadeev, Elizaveta E. Mass, Tatiana N. Poletova, Liliana V. Sumyatina & Tatyana V. Denisova. (2022) Non-invasive diagnosis and non-surgical treatment of endometriosis: A review. Gynecology 24:3, pages 167-173.
Crossref
Libera Troìa & Stefano Luisi. (2022) Estro-Progestins and Pain Relief in Endometriosis. Endocrines 3:2, pages 349-366.
Crossref
Ezgi Darici & Engin Oral. 2022. Endometriosis and Adenomyosis. Endometriosis and Adenomyosis 531 556 .
Gennady T. Sukhikh, Leila V. Adamyan, Svetlana O. Dubrovina, Igor I. Baranov, Vitaly F. Bezhenar, Andrey V. Kozachenko, Viktor E. Radzinsky, Mekan R. Orazov, Maria I. Yarmolinskaya & Jan I. Olofsson. (2021) Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study. Fertility and Sterility 116:6, pages 1568-1577.
Crossref
Stefania Greco, Pamela Pellegrino, Alessandro Zannotti, Giovanni Delli Carpini, Andrea Ciavattini, Fernando M. Reis & Pasquapina Ciarmela. (2021) Phytoprogestins: Unexplored Food Compounds with Potential Preventive and Therapeutic Effects in Female Diseases. Nutrients 13:12, pages 4326.
Crossref
A.M. Hryhorenko. (2021) Gestagenes in the treatment of endometriosis: efficiency, safety, bioequivalence, transferability. REPRODUCTIVE ENDOCRINOLOGY:61, pages 72-75.
Crossref
Srithean LertvikoolYada Tingthanatikul, Woradej HongsakornChartchai SrisombutKatanyuta NakpalatSawaek Weerakiet. (2021) Outcomes of Laparoscopic Partial Cystectomy of Bladder Endometriosis: A Report of 18 Thai Women. Women's Health Reports 2:1, pages 369-374.
Crossref
Vishal Bahall, Lance De Barry, Suman S Harry & Maria Bobb. (2021) Gross Ascites Secondary to Endometriosis: A Rare Presentation in Pre-Menopausal Women. Cureus.
Crossref
Ahmed I. Hassanin, Ahmed A. Youssef, Asmaa M. Yousef & Mohammed K. Ali. (2021) Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial. International Journal of Gynecology & Obstetrics 154:2, pages 263-269.
Crossref
Galina E. Chernukha, Madina R. Dumanovskaya & Lilia M. Ilina. (2021) Ovarian endometriosis and fertility preservation problem. Gynecology 23:2, pages 110-116.
Crossref
Kalinkina O.B., Tezikov Yu.V., Lipatov I.S. & Aravina O.R.. (2021) EXPERIENCE OF LONG-TERM USE OF DIENOGEST FOR THE TREATMENT OF ADENOMYOSIS. "Medical & pharmaceutical journal "Pulse", pages 92-99.
Crossref
N.I. Tapilskaya, A.V. Mironova, E.A. Silaeva, A.V. Shkarupa & R.I. Glushakov. (2021) Chronic pelvic pain syndrome in women: risk factors, differential diagnosis, treatment and prevention. Problemy reproduktsii 27:2, pages 56.
Crossref
E.N. Andreeva & E.V. Sheremetyeva. (2021) Chronic pelvic pain in patients of reproductive age with endometriosis. Problemy reproduktsii 27:1, pages 46.
Crossref
Konstantinos Nirgianakis, Cloé Vaineau, Lia Agliati, Brett McKinnon, Maria L. Gasparri & Michael D. Mueller. (2020) Risk factors for non‐response and discontinuation of Dienogest in endometriosis patients: A cohort study. Acta Obstetricia et Gynecologica Scandinavica 100:1, pages 30-40.
Crossref
Bogdan Doroftei, Theodora Armeanu, Radu Maftei, Ovidiu-Dumitru Ilie, Ana-Maria Dabuleanu & Constantin Condac. (2020) Abdominal Wall Endometriosis: Two Case Reports and Literature Review. Medicina 56:12, pages 727.
Crossref
Andrew Zakhari, Darl Edwards, Michelle Ryu, John J. Matelski, Olga Bougie & Ally Murji. (2020) Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysis. Journal of Minimally Invasive Gynecology 27:7, pages 1503-1510.
Crossref